PharmaSeq has developed a technology platform - microchip and nanochip technologies for DNA diagnostics, genomics, and proteomio. Diesignated p-Chip® - the firm's stock-in-trade is an ultra-small microtransponder tag that can be used across many and varied contexts to include tagging, tracking and authenticating consumer goods, industrial goods and small animals e.g. laboratory mice. The company is also using their p-Chip platform to develop applications for life science research and clinical diagnostic markets and is also offering Chip tags in bulk for gluing onto (or embedding into) a range of objects, Examples: housed in a syringe for injecting into the tails of laboratory mice, static reading wands for securely reading the p-Chip identification number, and various accessories. Products currently in development include chemically modified p-Chips that have various types of biochemical probes attached to their surfaces, such as DNA, antibodies or peptides, and the reagent kits that go along with them. PharmaSeq is also developing modified p-Chips that have sensors placed on them for measuring environmental properties, such as pH and that will be read by a dynamic, flow-based p-Chip reading system, which is under development.
